Counts
| Attribute Name | Description | Count (MRSAT.RRF) |
|---|---|---|
| SMQ_TERM_ADDVERSION | Standardised MedDRA Query (SMQ) Addition Version. Version of MedDRA in which term was added to the SMQ. | 96378 |
| SMQ_TERM_CAT | Standardised MedDRA Query (SMQ) Term Category. A single alphabetical letter indicating the category of the term for application of the SMQ algorithm. If the SMQ does not use algorithms, then all Term_category values are assigned "A." For a child SMQ, this field is assigned "S." | 96378 |
| SMQ_TERM_LMVERSION | Standardised MedDRA Query (SMQ) Last Modified Version. Version of MedDRA in which term was last modified in the SMQ. | 96378 |
| SMQ_TERM_SCOPE | Standardised MedDRA Query (SMQ) Term Scope. Defines the MedDRA term as a member of the broad scope (1), narrow scope (2) of the SMQ search, or a child SMQ (0) (zero). | 96378 |
| SMQ_TERM_STATUS | Standardised MedDRA Query (SMQ) Term Status. Identifies a term as active ("A") or inactive ("I") within this SMQ. | 96378 |
| SMQ_TERM_WEIGHT | Standardised MedDRA Query (SMQ) Term Weight. Used for some SMQ algorithms; "0" is used as default. | 96378 |
| MXR | MedDRA cross reference to COSTART, HARTS, ICD9, ICD-9-CM, J-ART or WHOART | 41678 |
| SMQ_TERM_LEVEL | Standardised MedDRA Query (SMQ) Term Level. The MedDRA hierarchy level of a term (4=PT, 5=LLT) or 0 (zero) for a child SMQ. | 34269 |
| MPS | MedDRA primary SOC (PTs may have multiple treepositions, but each has a primary soc) | 18209 |
| SMQ_ALGO | Standardised MedDRA Query (SMQ) Algorithm. Boolean expression of algorithm for the SMQ. "N" if the SMQ does not utilize an algorithm. | 151 |
| SMQ_LEVEL | Standardised MedDRA Query (SMQ) Level. Value between 1 and 5 identifying the level of the SMQ within the hierarchy of SMQs; 1 is the most general, 5 is the most narrow. | 151 |
| SMQ_STATUS | Standardised MedDRA Query (SMQ) Status. "A" = active; "I" = inactive. | 151 |
| SMQ_SOURCE | Standardised MedDRA Query (SMQ) Source. Source for the development of the SMQ, e.g. medical references. | 116 |
| SOS | Scope Statement | 78 |
| MISO | MedDRA Serial Code International SOC Sort Order Digit (01-26) | 26 |
| FROMRSAB | Root source abbreviation for the "from" identifiers of a map set | 2 |
| FROMVSAB | Versioned source abbreviation for the "from" identifiers of a map set | 2 |
| MAPSETRSAB | Root source abbreviation for a map set | 2 |
| MAPSETTYPE | Indicates the nature of a map set. Its value is map set specific. It can be used to indicate the inclusion of one to one, one to many and choices of maps. | 2 |
| MAPSETVERSION | Version of the map set | 2 |
| MAPSETVSAB | Versioned source abbreviation for a map set | 2 |
| MTH_MAPFROMCOMPLEXITY | Indicates the complexity of "from" expressions used in a map set | 2 |
| MTH_MAPFROMEXHAUSTIVE | Indicates whether or not the "from" source of a map set is completely mapped | 2 |
| MTH_MAPSETCOMPLEXITY | Indicates the overall complexity of a map set | 2 |
| MTH_MAPTOCOMPLEXITY | Indicates the complexity of "to" expressions in a map set | 2 |
| MTH_MAPTOEXHAUSTIVE | Indicates whether or not the "to" source is completely mapped | 2 |
| TORSAB | Root source abbreviation for the "to" identifiers of a map set | 2 |
| TOVSAB | Versioned source abbreviation for the "to" identifiers of a map set | 2 |
Notes
- Attributes included every discrete piece of information about a concept, an atom, or a relationship that is not part of the basic Metathesaurus concept structure or distributed in one of the relationship files.
- Attribute Names (ATN) are based on source documentation or NLMs understanding of the source.
- Sample attribute values (ATV) are provided for each ATN in the source.
- Sample data highlight examples of ATNs and Attribute Values (ATV) in MRSAT.RRF.
- See Appendix B.2 for a complete list of attribute names.
- See UMLS Documentation Section 2.7.1.3.5 for more information on MRSAT.RRF.
Sample Data
SMQ_TERM_ADDVERSION
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C0018802 | R92073458 | RUI | SMQ_TERM_ADDVERSION | 10.0 | Heart failure, congestive |
| C1869016 | R92106374 | RUI | SMQ_TERM_ADDVERSION | 8.0 | Liver neoplasms, benign (SMQ) |
| C0156193 | R92083400 | RUI | SMQ_TERM_ADDVERSION | 8.0 | Other sequelae of chronic liver disease |
| C0855395 | R92066300 | RUI | SMQ_TERM_ADDVERSION | 8.0 | Coagulation factor IX level low |
| C0542063 | R92076189 | RUI | SMQ_TERM_ADDVERSION | 8.0 | Jaundice hemologous serum-like |
| C1869021 | R92106971 | RUI | SMQ_TERM_ADDVERSION | 8.0 | Events specifically reported as alcohol-related (SMQ) |
| C0857584 | R92068764 | RUI | SMQ_TERM_ADDVERSION | 8.0 | Direct Coombs test abnormal |
| C0158967 | R92076757 | RUI | SMQ_TERM_ADDVERSION | 10.0 | Late anemia due to isoimmunization of fetus or newborn |
| C1869024 | R92107245 | RUI | SMQ_TERM_ADDVERSION | 8.0 | Severe cutaneous adverse reactions (SMQ) |
SMQ_TERM_CAT
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C0858060 | R92088555 | RUI | SMQ_TERM_CAT | A | Serum creatine phosphokinase abnormal |
| C0700225 | R92088565 | RUI | SMQ_TERM_CAT | A | Serum creatinine increased |
| C1869012 | R92105876 | RUI | SMQ_TERM_CAT | A | Liver related investigations, signs and symptoms (SMQ) |
| C1869017 | R92106429 | RUI | SMQ_TERM_CAT | A | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) |
| C0023911 | R92077325 | RUI | SMQ_TERM_CAT | A | Liver transplant |
| C0858200 | R92061432 | RUI | SMQ_TERM_CAT | A | Anemia hemolytic indirect Coombs positive |
| C0241128 | R92081155 | RUI | SMQ_TERM_CAT | A | Nikolsky's sign |
| C0239340 | R92081700 | RUI | SMQ_TERM_CAT | A | Oedema lower limb |
| C0858619 | R92097801 | RUI | SMQ_TERM_CAT | A | Corneal edema postoperative |
SMQ_TERM_LMVERSION
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C1869007 | R92105043 | RUI | SMQ_TERM_LMVERSION | 7.1 | Rhabdomyolysis/myopathy (SMQ) |
| C0855406 | R92101519 | RUI | SMQ_TERM_LMVERSION | 8.0 | Coagulation factor VII level abnormal |
| C1869023 | R92107152 | RUI | SMQ_TERM_LMVERSION | 8.0 | Haemolytic disorders (SMQ) |
| C0011606 | R92068362 | RUI | SMQ_TERM_LMVERSION | 8.0 | Dermatitis exfoliative NOS |
| C1869024 | R92107428 | RUI | SMQ_TERM_LMVERSION | 8.0 | Severe cutaneous adverse reactions (SMQ) |
| C1869038 | R92107598 | RUI | SMQ_TERM_LMVERSION | 8.1 | Anaphylactic reaction (SMQ) |
| C0234940 | R92075330 | RUI | SMQ_TERM_LMVERSION | 8.1 | Inflammatory edema reaction |
| C1869025 | R92108381 | RUI | SMQ_TERM_LMVERSION | 10.1 | Acute pancreatitis (SMQ) |
| C1869027 | R92109304 | RUI | SMQ_TERM_LMVERSION | 8.1 | Angioedema (SMQ) |
SMQ_TERM_SCOPE
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C0232197 | R92064719 | RUI | SMQ_TERM_SCOPE | 1 | Cardiac fibrillation NOS |
| C1869007 | R92105125 | RUI | SMQ_TERM_SCOPE | 1 | Rhabdomyolysis/myopathy (SMQ) |
| C1869008 | R92105324 | RUI | SMQ_TERM_SCOPE | 1 | Acute renal failure (SMQ) |
| C1869012 | R92105968 | RUI | SMQ_TERM_SCOPE | 1 | Liver related investigations, signs and symptoms (SMQ) |
| C1869023 | R92107064 | RUI | SMQ_TERM_SCOPE | 2 | Haemolytic disorders (SMQ) |
| C0580380 | R92087829 | RUI | SMQ_TERM_SCOPE | 1 | Reticulocyte count abnormal NOS |
| C1869038 | R92107532 | RUI | SMQ_TERM_SCOPE | 1 | Anaphylactic reaction (SMQ) |
| C1869038 | R92107757 | RUI | SMQ_TERM_SCOPE | 1 | Anaphylactic reaction (SMQ) |
| C0542571 | R92081681 | RUI | SMQ_TERM_SCOPE | 1 | Oedema face |
SMQ_TERM_STATUS
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C0587246 | R92093474 | RUI | SMQ_TERM_STATUS | A | Weakness of limbs |
| C0858054 | R92085221 | RUI | SMQ_TERM_STATUS | A | Plasma cholinesterase decreased |
| C0854794 | R92078032 | RUI | SMQ_TERM_STATUS | A | Malignant liver tumour recurrent |
| C1869019 | R92106745 | RUI | SMQ_TERM_STATUS | A | Possible liver-related coagulation and bleeding disturbances (SMQ) |
| C0019159 | R92073807 | RUI | SMQ_TERM_STATUS | A | Hep A |
| C0020649 | R92063466 | RUI | SMQ_TERM_STATUS | A | Blood pressure drop arterial |
| C0033774 | R92076136 | RUI | SMQ_TERM_STATUS | A | Itching |
| C0151602 | R92086706 | RUI | SMQ_TERM_STATUS | A | Puffiness face |
| C1869026 | R92108541 | RUI | SMQ_TERM_STATUS | A | Agranulocytosis (SMQ) |
SMQ_TERM_WEIGHT
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C1869008 | R92105371 | RUI | SMQ_TERM_WEIGHT | 0 | Acute renal failure (SMQ) |
| C0541781 | R92061906 | RUI | SMQ_TERM_WEIGHT | 0 | Arms swollen red hot |
| C0239819 | R92094973 | RUI | SMQ_TERM_WEIGHT | 0 | Edema hands |
| C1869015 | R92106264 | RUI | SMQ_TERM_WEIGHT | 0 | Liver neoplasms, malignant and unspecified (SMQ) |
| C1869023 | R92107078 | RUI | SMQ_TERM_WEIGHT | 0 | Haemolytic disorders (SMQ) |
| C0160887 | R92063290 | RUI | SMQ_TERM_WEIGHT | 0 | Blister of hip, thigh, leg, and ankle, without mention of infection |
| C1869038 | R92107659 | RUI | SMQ_TERM_WEIGHT | 0 | Anaphylactic reaction (SMQ) |
| C0002994 | R92086991 | RUI | SMQ_TERM_WEIGHT | 0 | Quincke's edema |
| C0002874 | R92061850 | RUI | SMQ_TERM_WEIGHT | 0 | Aplastic anemia |
MXR
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0151888 | A0422403 | L0307340 | S0378733 | AUI | 10021089 | MXR | J-ART: 0757 | Hyporeflexia |
| C0021177 | A1603178 | L0021177 | S1642075 | AUI | 10024421 | MXR | COSTART: LIBIDO INC | Libido increased |
| C0234934 | A1114670 | L0318955 | S1056656 | AUI | 10046755 | MXR | WHOART: 0044003 | Urticaria vesiculosa |
| C0600097 | A0793925 | L0317645 | S0733738 | AUI | 10039897 | MXR | HARTS: 4597 | Sedation |
| C0034212 | A0108168 | L0034212 | S0078946 | AUI | 10037632 | MXR | J-ART: 073004 | Pyoderma |
| C0012002 | A0048196 | L0012002 | S0032532 | AUI | 10012762 | MXR | ICD9CM: 93.34 | Diathermy |
| C0035934 | A0453977 | L0035934 | S0400982 | AUI | 10039281 | MXR | WHOART: 0694003 | Rubinstein-Taybi syndrome |
| C0155626 | A0275911 | L0182490 | S0247070 | AUI | 10000891 | MXR | ICD9: 410 | Acute myocardial infarction |
| C0027059 | A2849442 | L0027059 | S0064653 | AUI | 10028606 | MXR | COSTART: MYOCARDITIS | Myocarditis |
SMQ_TERM_LEVEL
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0022672 | A0242649 | L0001354 | S0218507 | CODE | 10001049 | SMQ_TERM_LEVEL | 5 | Acute renal failure with lesion of tubular necrosis |
| C0241039 | A8254646 | L1382249 | S1643356 | CODE | 10033412 | SMQ_TERM_LEVEL | 5 | Pain in (l) shoulder |
| C0858447 | A1575047 | L1367047 | S1618073 | CODE | 10035459 | SMQ_TERM_LEVEL | 5 | Plasma urea abnormal |
| C0520861 | A1603153 | L0856736 | S1642055 | CODE | 10047240 | SMQ_TERM_LEVEL | 4 | Venous pressure jugular increased |
| C0086565 | A1595788 | L1378121 | S1635701 | CODE | 10019674 | SMQ_TERM_LEVEL | 5 | Hepatic function disorder |
| C0013404 | A1586433 | L0287745 | S1627568 | CODE | 10006338 | SMQ_TERM_LEVEL | 5 | Breathing difficult |
| C0231848 | A1578043 | L0278900 | S1620475 | CODE | 10020468 | SMQ_TERM_LEVEL | 5 | Hunger air |
| C0162285 | A0879539 | L0749209 | S0819939 | CODE | 10049850 | SMQ_TERM_LEVEL | 5 | Blepharoedema |
| C0857092 | A1596810 | L1378503 | S1636611 | CODE | 10013860 | SMQ_TERM_LEVEL | 5 | Duodenal ulcer-type symptoms |
MPS
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0003708 | A0026063 | L0003708 | S0015566 | SDUI | 10003074 | MPS | 10029205 | Arachnoiditis |
| C0006444 | A0033373 | L0006444 | S0021064 | SDUI | 10006811 | MPS | 10028395 | Bursitis |
| C0262918 | A1598543 | L0300438 | S1638158 | SDUI | 10015829 | MPS | 10015919 | Extraocular muscle paresis |
| C0015672 | A0058330 | L0015672 | S0040757 | SDUI | 10016256 | MPS | 10018065 | Fatigue |
| C0020428 | A0070579 | L0020428 | S0050324 | SDUI | 10020571 | MPS | 10014698 | Hyperaldosteronism |
| C0023501 | A0731385 | L0023501 | S0676134 | SDUI | 10024328 | MPS | 10005329 | Leukaemoid reaction |
| C0852654 | A1572941 | L1365905 | S1616476 | SDUI | 10000021 | MPS | 10010331 | 21-hydroxylase deficiency |
| C1262481 | A1597778 | L0299378 | S1637445 | SDUI | 10017902 | MPS | 10017947 | Gastroenteritis eosinophilic |
| C0037995 | A0118725 | L0037995 | S0087599 | SDUI | 10041642 | MPS | 10042613 | Splenectomy |
SMQ_ALGO
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869007 | A12057867 | L6511681 | S7585665 | SDUI | 20000002 | SMQ_ALGO | N | Rhabdomyolysis/myopathy (SMQ) |
| C1869091 | A12057875 | L6511505 | S7585241 | SDUI | 20000004 | SMQ_ALGO | N | Cardiac failure (SMQ) |
| C1869010 | A12057517 | L6511484 | S7585620 | SDUI | 20000006 | SMQ_ALGO | N | Possible drug related hepatic disorders - comprehensive search (SMQ) |
| C1869012 | A12057868 | L6511726 | S7585510 | SDUI | 20000008 | SMQ_ALGO | N | Liver related investigations, signs and symptoms (SMQ) |
| C1869013 | A12056802 | L6511443 | S7585261 | SDUI | 20000009 | SMQ_ALGO | N | Cholestasis and jaundice of hepatic origin (SMQ) |
| C1869014 | A12057518 | L6511652 | S7585428 | SDUI | 20000010 | SMQ_ALGO | N | Hepatitis, non-infectious (SMQ) |
| C1869015 | A12056621 | L6511665 | S7585509 | SDUI | 20000011 | SMQ_ALGO | N | Liver neoplasms, malignant and unspecified (SMQ) |
| C1869017 | A12057343 | L6511463 | S7585427 | SDUI | 20000013 | SMQ_ALGO | N | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) |
| C1869018 | A12057698 | L6511446 | S7585282 | SDUI | 20000014 | SMQ_ALGO | N | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) |
SMQ_LEVEL
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869006 | A12057156 | L6511616 | S7585752 | SDUI | 20000001 | SMQ_LEVEL | 1 | Torsade de pointes/QT prolongation (SMQ) |
| C1869007 | A12057867 | L6511681 | S7585665 | SDUI | 20000002 | SMQ_LEVEL | 1 | Rhabdomyolysis/myopathy (SMQ) |
| C1869091 | A12057875 | L6511505 | S7585241 | SDUI | 20000004 | SMQ_LEVEL | 1 | Cardiac failure (SMQ) |
| C1869009 | A12057733 | L6511462 | S7585426 | SDUI | 20000005 | SMQ_LEVEL | 1 | Hepatic disorders (SMQ) |
| C1869011 | A12056801 | L6511901 | S7585621 | SDUI | 20000007 | SMQ_LEVEL | 3 | Possible drug related hepatic disorders - severe events only (SMQ) |
| C1869012 | A12057868 | L6511726 | S7585510 | SDUI | 20000008 | SMQ_LEVEL | 3 | Liver related investigations, signs and symptoms (SMQ) |
| C1869013 | A12056802 | L6511443 | S7585261 | SDUI | 20000009 | SMQ_LEVEL | 3 | Cholestasis and jaundice of hepatic origin (SMQ) |
| C1869014 | A12057518 | L6511652 | S7585428 | SDUI | 20000010 | SMQ_LEVEL | 4 | Hepatitis, non-infectious (SMQ) |
| C1869015 | A12056621 | L6511665 | S7585509 | SDUI | 20000011 | SMQ_LEVEL | 4 | Liver neoplasms, malignant and unspecified (SMQ) |
SMQ_STATUS
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869006 | A12057156 | L6511616 | S7585752 | SDUI | 20000001 | SMQ_STATUS | A | Torsade de pointes/QT prolongation (SMQ) |
| C1869007 | A12057867 | L6511681 | S7585665 | SDUI | 20000002 | SMQ_STATUS | A | Rhabdomyolysis/myopathy (SMQ) |
| C1869091 | A12057875 | L6511505 | S7585241 | SDUI | 20000004 | SMQ_STATUS | A | Cardiac failure (SMQ) |
| C1869009 | A12057733 | L6511462 | S7585426 | SDUI | 20000005 | SMQ_STATUS | A | Hepatic disorders (SMQ) |
| C1869011 | A12056801 | L6511901 | S7585621 | SDUI | 20000007 | SMQ_STATUS | A | Possible drug related hepatic disorders - severe events only (SMQ) |
| C1869013 | A12056802 | L6511443 | S7585261 | SDUI | 20000009 | SMQ_STATUS | A | Cholestasis and jaundice of hepatic origin (SMQ) |
| C1869016 | A12057869 | L6511664 | S7585508 | SDUI | 20000012 | SMQ_STATUS | A | Liver neoplasms, benign (SMQ) |
| C1869017 | A12057343 | L6511463 | S7585427 | SDUI | 20000013 | SMQ_STATUS | A | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) |
| C1869018 | A12057698 | L6511446 | S7585282 | SDUI | 20000014 | SMQ_STATUS | A | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) |
SMQ_SOURCE
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869006 | A12057156 | L6511616 | S7585752 | SDUI | 20000001 | SMQ_SOURCE | Zipes DP. Specific arrhythmias: diagnosis and treatment. Heart Disease: A Textbook of Cardiovascular Medicine (5th Ed). Braunwald E (Ed). WB Saunders: Philadelphia, 1997, pg. 640-704. Marriott HJL and Conover MB. Polymorphic ventricular tachycardia. Advanced Concepts in Arrhythmias (3rd Ed). Mosby: New York, 1998, pg. 293-310. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders. Pharmacoepidemiology and Drug Safety 1998; 7:351-357. Torsade de pointes. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pg. 81-82 Josephson ME and Zimetbaum P. The tachyarrhythmias. Harrison's Principles of Internal Medicine (15th Ed). Braunwald E, Fauci AS, Kasper DL et al (Eds). McGraw-Hill: New York, 2001, pg. 1292-1309. Bauman JL and Schoen MD. Arrhythmias. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, 2002, pg. 273-303. | Torsade de pointes/QT prolongation (SMQ) |
| C1869007 | A12057867 | L6511681 | S7585665 | SDUI | 20000002 | SMQ_SOURCE | Basic requirements for the use of terms for reporting adverse drug reactions (IV). Pharmacoepidemiology and Drug Safety 1993; 2:149-153. Myopathy. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pg. 16-17. Poels PJE and Gabreels FJM. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 1993; 95:175-192. Omar MA, Wilson JP, and Cox, TS. Rhabdomyolysis and HMG-CoA reductase inhibitors. Annals Pharmacother 2001; 35:1096-1107. Prendergast BD and George CF. Drug-induced rhabdomyolysis - mechanisms and management. Postgrad Med J 1993; 69:333-336. | Rhabdomyolysis/myopathy (SMQ) |
| C1869008 | A12056800 | L6511448 | S7585289 | SDUI | 20000003 | SMQ_SOURCE | The Merck Manual, 17th Edition Cecil Textbook of Medicine, 19th Edition Harrison's Principles of Internal Medicine, 13th Edition | Acute renal failure (SMQ) |
| C1869091 | A12057875 | L6511505 | S7585241 | SDUI | 20000004 | SMQ_SOURCE | Council for International Organisations of Medical Sciences (CIOMS). Reporting Adverse Drug Reactions. Definition of terms and criteria for their use. 1999: p 64-65 | Cardiac failure (SMQ) |
| C1869024 | A12057520 | L6511492 | S7585682 | SDUI | 20000020 | SMQ_SOURCE | Roujeau JC and Stern RS. Severe adverse cutaneous reactions to drugs. New England Journal of Medicine 1994; 331: 1272-1285. Reporting Adverse Drug Reactions. Definitions of terms and criteria for their use. CIOMS publication, Geneva 1999. | Severe cutaneous adverse reactions (SMQ) |
| C1869038 | A12057161 | L6511588 | S7585462 | SDUI | 20000021 | SMQ_SOURCE | 1 The Merck Manual. 15th edition. Merck, Sharp & Dohme Research Laboratories. (1987): 306-7 | Anaphylactic reaction (SMQ) |
| C1869025 | A12057005 | L6511764 | S7585273 | SDUI | 20000022 | SMQ_SOURCE | 1. Anonymous. Pancreatitis. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pp 53-54 2. Berardi RR and Montgomery PA. Pancreatitis. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, NY. 1999. pp 701-715 3. Greenberger NJ, Toskes PP, and Isselbacher KJ. Acute and chronic pancreatitis. Harrison's Principles of Internal Medicine (14th Ed). Fauci AS, Braunwald E, Isselbacher KJ et al (Eds). McGraw-Hill: New York, NY. 1998. pp 1741-1752 | Acute pancreatitis (SMQ) |
| C1869026 | A12056983 | L6511876 | S7585355 | SDUI | 20000023 | SMQ_SOURCE | 1. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Geneva, 1999 2. Harrison's Principles of Internal Medicine, 15th edition, Eugene Braunwald [et al.], McGraw-Hill, 2001 | Agranulocytosis (SMQ) |
| C1869027 | A12056622 | L6511474 | S7585499 | SDUI | 20000024 | SMQ_SOURCE | 1. Bankowski Z, Bruppacher R, Crusius I et al. Reporting adverse drug reactions, definition of terms and criteria for their use. Council for International Organizations of Medical Sciences (CIOMS) 1999 pp 12 -13 2. Dorland's Illustrated Medical Dictionary, 28th Edition 1994 p78 3. Braunwald E, Fauci A and Kasper D. Harrison's Principles of Internal Medicine, 15th Edition, 2001 p 341 and pp 1917-1918 4. Beers M and Berkow R. The Merck Manual of diagnosis and therapy, 17th edition, dated 1999 pp 1054-56 | Angioedema (SMQ) |
SOS
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869006 | A12057156 | L6511616 | S7585752 | SDUI | 20000001 | SOS | 1. Includes sudden and cardiac death terms as this is a frequent association with torsade de pointes. | Torsade de pointes/QT prolongation (SMQ) |
| C1869007 | A12057867 | L6511681 | S7585665 | SDUI | 20000002 | SOS | 1. Renal impairment/failure terms included because of the frequent association with rhabdomyolysis | Rhabdomyolysis/myopathy (SMQ) |
| C1869091 | A12057875 | L6511505 | S7585241 | SDUI | 20000004 | SOS | The CIOMS Working Group discussed in detail whether an algorithm could be applied to this SMQ based on the definition of cardiac failure provided. Such an algorithm, however, has not been tested by the CIOMS Working Group, therefore, the Working Group is requesting users to comment on the practical relevance of an algorithm approach. Such an algorithm could involve broad tersmsas follows: one oedema term, one dyspnoea term plus one clinical/sign/symptom or investigation making up 3 terms in total | Cardiac failure (SMQ) |
| C1869038 | A12057161 | L6511588 | S7585462 | SDUI | 20000021 | SOS | The following algorithm is used: All narrow search terms as well as: If one term from category B and one term from category C is present, or If one term from (category B or category C) plus one term from category D. | Anaphylactic reaction (SMQ) |
| C1869025 | A12057005 | L6511764 | S7585273 | SDUI | 20000022 | SOS | To apply algorithm - A report is considered a relevant case for further review if: 1) it includes a term from Category A (Narrow terms) OR 2) it includes at least one term from Category B (the list of laboratory values) and at least one term from Category C (the list of signs and symptoms) | Acute pancreatitis (SMQ) |
| C1869026 | A12056983 | L6511876 | S7585355 | SDUI | 20000023 | SOS | If possible, full blood counts and repeated white blood cell counts should be reported, sought for in follow up, and coded. Concerning database queries with broad search terms, additionally coded data on hematological values help to find relevant cases more easily. In case laboratory values are not coded in a database, individual review is then needed to decide upon relevance in the context of agranulocytosis. | Agranulocytosis (SMQ) |
| C1869030 | A12057521 | L6511580 | S7585405 | SDUI | 20000027 | SOS | Cases with no link to the category "Cytopenia and haematopoietic disorders affecting more than one type of blood cells" need to be reviewed for combinations of AEs/ADRs assigned to at least two of the other three SMQs to find all such cases. All types of potential combinations appear possible and need to be considered. | Haematopoietic cytopenias (SMQ) |
| C1869031 | A12056805 | L6511767 | S7585299 | SDUI | 20000028 | SOS | Cases with no link to the category "Cytopenia and haematopoietic disorders affecting more than one type of blood cells" need to be reviewed for combinations of AEs/ADRs assigned to at least two of the other three SMQs to find all such cases. All types of potential combinations appear possible and need to be considered. | Cytopenia and haematopoietic disorders affecting more than one type of blood cell (SMQ) |
| C1869032 | A12057344 | L6511573 | S7585354 | SDUI | 20000029 | SOS | Cases with no link to the category "Cytopenia and haematopoietic disorders affecting more than one type of blood cells" need to be reviewed for combinations of AEs/ADRs assigned to at least two of the other three SMQs to find all such cases. All types of potential combinations appear possible and need to be considered. | Erythropenia (SMQ) |
MISO
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1261322 | A0976668 | L0861064 | S0919672 | SDUI | 10022891 | MISO | 23 | Investigations |
| C0018799 | A1588768 | L0537218 | S1629626 | SDUI | 10007541 | MISO | 11 | Cardiac disorders |
| C0851352 | A2016522 | L1376503 | S2162599 | SDUI | 10010331 | MISO | 21 | Congenital, familial and genetic disorders |
| C0851353 | A1585002 | L1372278 | S1626383 | SDUI | 10005329 | MISO | 03 | Blood and lymphatic system disorders |
| C0027765 | A1596081 | L0297185 | S1635977 | SDUI | 10029205 | MISO | 08 | Nervous system disorders |
| C0015397 | A1595746 | L0012705 | S1635657 | SDUI | 10015919 | MISO | 09 | Eye disorders |
| C0851354 | A1595679 | L1378038 | S1635566 | SDUI | 10013993 | MISO | 10 | Ear and labyrinth disorders |
| C0851355 | A1595973 | L1378186 | S1635875 | SDUI | 10038738 | MISO | 13 | Respiratory, thoracic and mediastinal disorders |
| C0017178 | A1595807 | L0161543 | S1635716 | SDUI | 10017947 | MISO | 14 | Gastrointestinal disorders |
FROMRSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | FROMRSAB | MDR | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | FROMRSAB | MDR | MDR11_1 to CST95 Mappings |
FROMVSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | FROMVSAB | MDR11_1 | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | FROMVSAB | MDR11_1 | MDR11_1 to CST95 Mappings |
MAPSETRSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | MAPSETRSAB | MDR | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | MAPSETRSAB | MDR | MDR11_1 to CST95 Mappings |
MAPSETTYPE
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | MAPSETTYPE | MedDRA to ICD9CM Mappings | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | MAPSETTYPE | MedDRA to COSTART Mappings | MDR11_1 to CST95 Mappings |
MAPSETVERSION
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | MAPSETVERSION | 200809 | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | MAPSETVERSION | 200809 | MDR11_1 to CST95 Mappings |
MAPSETVSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | MAPSETVSAB | MDR11_1 | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | MAPSETVSAB | MDR11_1 | MDR11_1 to CST95 Mappings |
MTH_MAPFROMCOMPLEXITY
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | MTH_MAPFROMCOMPLEXITY | SINGLE CODE | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | MTH_MAPFROMCOMPLEXITY | SINGLE CODE | MDR11_1 to CST95 Mappings |
MTH_MAPFROMEXHAUSTIVE
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | MTH_MAPFROMEXHAUSTIVE | N | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | MTH_MAPFROMEXHAUSTIVE | N | MDR11_1 to CST95 Mappings |
MTH_MAPSETCOMPLEXITY
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | MTH_MAPSETCOMPLEXITY | ONE_TO_ONE | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | MTH_MAPSETCOMPLEXITY | ONE_TO_ONE | MDR11_1 to CST95 Mappings |
MTH_MAPTOCOMPLEXITY
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | MTH_MAPTOCOMPLEXITY | SINGLE CODE | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | MTH_MAPTOCOMPLEXITY | SINGLE CODE | MDR11_1 to CST95 Mappings |
MTH_MAPTOEXHAUSTIVE
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | MTH_MAPTOEXHAUSTIVE | N | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | MTH_MAPTOEXHAUSTIVE | N | MDR11_1 to CST95 Mappings |
TORSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | TORSAB | ICD9CM | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | TORSAB | CST | MDR11_1 to CST95 Mappings |
TOVSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2242749 | A15837029 | L8082422 | S10132036 | CODE | MTHU000002 | TOVSAB | ICD9CM_1998 | MDR11_1 to ICD9CM_1998 Mappings |
| C2242750 | A15837158 | L8082421 | S10132035 | CODE | MTHU000001 | TOVSAB | CST95 | MDR11_1 to CST95 Mappings |
